The binding and distribution of albendazole and its principal metabolites in Giardia duodenalis.

Article Details

Citation
Copy to clipboard

Oxberry ME, Reynoldson JA, Thompson RC

The binding and distribution of albendazole and its principal metabolites in Giardia duodenalis.

J Vet Pharmacol Ther. 2000 Jun;23(3):113-20.

PubMed ID
11110097 [ View in PubMed
]
Abstract

Trophozoites of the protozoan parasite Giardia duodenalis were exposed to various albendazole concentrations for 4 h, washed, fixed and incubated with antibodies raised against albendazole and its two major metabolites albendazole sulphoxide and albendazole sulphone. Tubulin antibodies were also used. A peroxidase- or FITC-conjugated secondary antibody was used to detect the primary antibody with transmission electron microscopy or confocal laser scanning microscopy, respectively. Albendazole, a benzimidazole compound, was detected in the mid-dorsal region of trophozoites, albendazole sulphoxide in the posterior-dorsal region and albendazole sulphone in clusters above the median bodies. Tubulin was recognised in the ventral disk. This is the first indication that G. duodenalis may be capable of metabolising albendazole and the potential path of the metabolised drug traced within the trophozoite. Fluorescence measurements revealed that albendazole sulphoxide binding decreased and albendazole sulphone binding increased with exposure of the trophozoites to increasing albendazole concentration. This indicates that if albendazole was being metabolised by trophozoites, it occurred to a greater extent following exposure to higher albendazole concentrations.

DrugBank Data that Cites this Article

Drugs